Latest News

View all
Amgen to acquire Teneobio for $2.5 billion
Jul 27, 2021

For the development of a new class of biologics, Amgen announced to acquire Teneobio Inc. for approximately $2.5 billlion. Teneobio is a clinical stage …

BD acquires Massachusetts based Tepha, Inc.
Jul 27, 2021

To boost new innovations in soft tissue repair and regeneration, BD (Becton, Dickinson and Company) has acquired Tepha, Inc. The Massachusetts based Tepha is …

DSM acquires eubiotics start-up Midori USA for $63 million
Jul 27, 2021

Royal DSM to improve the health and environmental impact of animals has acquired remaining stake of Midori USA, Inc. for USD 63 million. Boston …

Abbott announces R&D investment in Clonmel, Ireland
Jul 27, 2021

Abbott, the leading health science company has announced an investment in research and development in Ireland. The investment at Clonmel Research and Development Centre …

Catalent expands Italian facility with $100 million investment
Jul 21, 2021

In order to increase biologics manufacturing capabilities in Europe, Catalent announced to invest $100 million. The plan includes the expansion of Anagni facility in, …

Latest Videos

View all

News By Sector

Amgen to acquire Teneobio for $2.5 billion

For the development of a new class of biologics, Amgen announced to acquire Teneobio Inc. for approximately $2.5 …

Posted On Jul 27, 2021

read more...
BD acquires Massachusetts based Tepha, Inc.

To boost new innovations in soft tissue repair and regeneration, BD (Becton, Dickinson and Company) has acquired Tepha, …

Posted On Jul 27, 2021

read more...
DSM acquires eubiotics start-up Midori USA for $63 million

Royal DSM to improve the health and environmental impact of animals has acquired remaining stake of Midori USA, …

Posted On Jul 27, 2021

read more...
Abbott announces R&D investment in Clonmel, Ireland

Abbott, the leading health science company has announced an investment in research and development in Ireland. The investment …

Posted On Jul 27, 2021

read more...
Catalent expands Italian facility with $100 million investment

In order to increase biologics manufacturing capabilities in Europe, Catalent announced to invest $100 million. The plan includes …

Posted On Jul 21, 2021

read more...
Grifols expands in Africa with new manufacturing plant in Nigeria

To strengthen presence in Africa, Grifols announced that it will establish an intravenous (IV) solutions production plant in …

Posted On Jul 19, 2021

read more...